Clinical and histological characteristics of Hodgkin's lymphoma in the Syrian coastal region
Abstract
Most data about cancer in Syria are estimated. This retrospective study aimed to analyze the clinical and pathologic characteristics of Hodgkin lymphoma (HL)
and their impact on the survival in the Syrian Coastal Zone. All new Hodgkin lymphoma patients with completed data who lived in SCZ and registered in the period 2010-2014
with the log book of the Unit for Radio- and Chemotherapy of Tishreen University Hospital (URCTUH) in Latakia, which was the only cancer unit in the SCZ between 2006-2016.
The age, sex, histological subtypes, treatment group, recurrence and death
when happened for each case were documented. 187 new cases of the SCZ-citizens
were diagnosed with Hodgkin lymphoma (HL) and referred to the URCTUH in the period
2010-2014. Just 169 cases were enrolled because of uncertain or incomplete data in 18
files. 89 (52.7%), 80 (47.3%) were males and females respectively. Male: female ratio
was 1.01. The histological subtypes were as the following: 91(53.8%), 52(30.8),
9(5.3%), 8(4.7%) and 9(5.3%) for nodular sclerosing (NSHL), mixed cellularity (MCHL),
lymphocyte rich(LRHL), lymphocyte depleted (LDHL) and nodular lymphocyte
predominant (NLPHL) respectively. Treatment groups based on European Organization
for Research and Treatment of Cancer (EORTC) classification: 31(18.3%), 68 (40.2%)
and 70 (41.4%) for limited stage (L), intermediate stage (I) and advanced stage (A). The
follow-up was ended on 15 Dec 2020 and 40 deaths were reported. 26 (29.2%) and 14
(17.5%) were males and females respectively. 5 years OS was 74.4% in males, 8.74%
in females, and 81.1% in both sexes. It was also significantly higher in younger patients,
non-advanced stages and non-relapsed cases. Systematic monitoring and analysis of Hodgkin lymphoma data would provide clinical, pathological and prognostic information which could improve the health care of these patients and the outcomes for this malignancy in Syria.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.